Home
|
Introduction
|
Transaction Bundle
|
Patient
|
Consent
|
GECCO Core
|
Anamnesis / Risk factors
|
Chronic lung diseases
|
Disorders of cardiovascular system
|
Chronic liver diseases
|
Rheumatological/immunological diseases
|
Human immunodeficiency virus infection
|
History of being a tissue or organ recipient
|
Diabetes mellitus
|
Malignant neoplastic diseases
|
Tobacco smoking status
|
Chronic neurological or mental diseases
|
Respiratory therapies
|
Chronic kidney diseases
|
History of travel
|
Gastrointestinal ulcers
|
Immunization status
|
Resuscitation status
|
Imaging
|
Imaging procedures
|
Radiological findings
|
Demographics
|
Pregnancy
|
Ethnic group
|
Biological sex
|
Date of birth
|
Age
|
Frailty score
|
Body weight
|
Body height
|
Epidemiological factors
|
Contact with persons suffering from Covid-19?
|
Complications
|
Complication
|
Onset of illness / Admission
|
Stage at diagnosis
|
Laboratory values
|
Laboratory value
|
SARS-CoV-2-RT-PCR
|
SARS-CoV-2 antibodies
|
Medication
|
Covid-19 therapy
|
ACE inhibitors
|
Immunoglobulins
|
Anticoagulation
|
Outcome at discharge
|
Respiratory outcome
|
Type of discharge
|
Follow-up swab result
|
Study enrollment / Inclusion criteria
|
Study enrolment due to Covid-19
|
Interventional studies participation
|
Symptoms
|
Symptom
|
Therapy
|
Dialysis / Hemofiltration
|
Apheresis
|
Prone position
|
ECMO therapy
|
Is the patient in the intensive care unit?
|
Ventilation type
|
Vital signs
|
PaCO2
|
PaO2
|
FiO2
|
pH
|
SOFA-Score
|
Respiratory rate
|
Diastolic blood pressure
|
Systolic blood pressure
|
Heart rate
|
Body temperature
|
Peripheral oxygen saturation
|
Terminologies
|